Sign Out
Retrovir chemoprophylaxis is indicated for use in HIV-positive pregnant women (over 14 weeks of gestation) for prevention of maternal-foetal HIV transmission and for primary prophylaxis of HIV infection in newborn infants.
Oral solution: Retrovir oral formulations are indicated in anti-retroviral combination therapy for Human Immunodeficiency Virus (HIV) infected adults and children.
IV infusion: Retrovir IV for Infusion is indicated for the short-term management of serious manifestations of Human Immunodeficiency Virus (HIV) infection in patients with Acquired Immune Deficiency Syndrome (AIDS) who are unable to take Retrovir oral formulations. If at all possible Retrovir IV should not be used as monotherapy for this indication (see Pharmacology: Pharmacodynamics under Actions).
Retrovir IV should only be used when oral treatment is not possible (except during labour and delivery - see Dosage & Administration).
